Adaptive Biotechnologies Q3 EPS $(0.11) Beats $(0.24) Estimate, Sales $26.1M Beat $22.09M Estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.24) by 54.17 percent. The company reported quarterly sales of $26.1 million which

Benzinga · 11/12/2019 21:15

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.24) by 54.17 percent. The company reported quarterly sales of $26.1 million which beat the analyst consensus estimate of $22.09 million by 18.15 percent.